China spares no efforts to ensure anti-COVID drug production, supply
STORY: China spares no efforts to ensure anti-COVID drug production, supply
DATELINE: Jan. 9, 2023
LENGTH: 00:02:09
LOCATION: Beijing
CATEGORY: HEALTH
SHOTLIST:
1. various of production lines
2. SOUNDBITE 1 (Chinese): YU XUEGANG, Ningxia Qiyuan Pharmaceutical Co., Ltd.
3. various of pharma firms speeding up anti-epidemic medicine production
4. SOUNDBITE 2 (Chinese): LI ZHILONG, Sinopharm Holding Ningxia Co., Ltd.
5. various of Luanzhen township hospital
6. SOUNDBITE 3 (Chinese): QIAO NAN, Director of medicine purchasing department of Luanzhen township hospital, Shaanxi
7. various of the local officials and staff working
8. various of the distribution of the health packages
9. SOUNDBITE 4 (Chinese): YAN CHENGWEI, Chongqing resident
STORYLINE:
China is implementing swift and concrete measures to accelerate drug development, production and supply, in order to guarantee better treatment of COVID-19 cases, as the country adjusts its epidemic response policy.
Targeting classic symptoms of the infection, China h
- Product Code
- ILEA001224510
- Registered date
- 2023/1/09 00:00:00
- Credit
- Xinhua / Kyodo News Images
- Media source
- Xinhua News Agency.All Rights Reserved
- Media size
- 1920 × 1080 pixel
- Deployment size
- 137.02(MB)*
*File size when opened in Photoshop, etc.